Classification of Adult-onset Diabetes in Five Subgroups in Pakistani Population

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age16+
SponsorGetz Pharma

About this trial

This study aims to classify adult-onset diabetes patients into distinct data-driven clusters, such as severe insulin-deficient, severe insulin-resistant, mild obesity-related, and mild age-related diabetes, based on clinical and biochemical characteristics. Using a cross-sectional design, data will be collected from individuals attending outpatient diabetes clinics at tertiary care hospitals in Pakistan. The study will analyze the distribution of metabolic and demographic characteristics within each cluster and assess subgroup-specific risks for diabetic complications. Additionally, the relationship between clustering variables and the risk of complications will be evaluated to enhance the understanding of diabetes heterogeneity and its impact on patient outcomes.

Eligibility criteria

Qualifiers

Patients of both genders whose age of disease onset was older than 16 years

Patients newly diagnosed with or previously diagnosed with T2D

Able and willing to provide written informed consent and to comply with the study

Disqualifiers

Patients with other medical comorbidities (not a complication of diabetes), such as malignancies.

Pregnancy

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

No trial groups listed

Locations

This trial has no locations

Sponsors and collaborators